levodopa has been researched along with Anhedonia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bekhbat, M; Felger, JC; Haroon, E; Li, Z; Lucido, MJ; Mehta, ND; Miller, AH; Treadway, MT; Woolwine, BJ | 1 |
| Borges, S; Coimbra, B; João Rodrigues, A; Miguel Pêgo, J; Soares-Cunha, C; Sousa, N | 1 |
| Matsui, K; Oguru, M; Oka, N; Okuda, B; Tachibana, H; Toda, K; Yamanishi, T | 1 |
| Corona-Morales, AA; Hernández, VS; Jáuregui-Huerta, F; Luquín, S; Medina, MP; Ruíz-Velasco, S; Zhang, L | 1 |
| Cannas, A; Fasano, A; Lang, AE; Marrosu, F; Marrosu, MG; Mulas, CS; Solla, P | 1 |
| Green, CE; Lane, SD; Schmitz, JM; Suchting, R; Vincent, JN; Wardle, MC | 1 |
2 trial(s) available for levodopa and Anhedonia
| Article | Year |
|---|---|
Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study.
Topics: Adult; Anhedonia; Depression; Depressive Disorder, Major; Dopamine; Humans; Inflammation; Levodopa; Magnetic Resonance Imaging; Neural Pathways; Reward | 2022 |
Anhedonia Is Associated with Poorer Outcomes in Contingency Management for Cocaine Use Disorder.
Topics: Adult; Anhedonia; Behavior Therapy; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Dopamine Agents; Double-Blind Method; Female; Humans; Individuality; Levodopa; Male; Middle Aged; Outcome Assessment, Health Care; Reward | 2017 |
4 other study(ies) available for levodopa and Anhedonia
| Article | Year |
|---|---|
Dopaminergic modulation of affective and social deficits induced by prenatal glucocorticoid exposure.
Topics: Affect; Age Factors; Anhedonia; Animals; Dexamethasone; Dopaminergic Neurons; Female; Glucocorticoids; Immobility Response, Tonic; Levodopa; Limbic System; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Social Behavior; Synaptic Transmission; Vocalization, Animal | 2013 |
Clinical correlates of anhedonia in patients with Parkinson's disease.
Topics: Aged; Anhedonia; Antiparkinson Agents; Anxiety; Depression; Female; Humans; Levodopa; Linear Models; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Quality of Life | 2013 |
Dopamine receptor dysregulation in hippocampus of aged rats underlies chronic pulsatile L-Dopa treatment induced cognitive and emotional alterations.
Topics: Age Factors; Anhedonia; Animals; Antiparkinson Agents; Behavior, Animal; Carbidopa; Cognition Disorders; Drug Combinations; Emotions; Hippocampus; Levodopa; Male; Mental Disorders; Motor Activity; Neurons; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D5; Spatial Learning | 2014 |
Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
Topics: Aged; Anhedonia; Apathy; Carbidopa; Dopamine Agonists; Drug Combinations; Female; Gels; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease; Substance Withdrawal Syndrome | 2015 |